Skip to main content
Clinical Trials/CTRI/2026/03/106722
CTRI/2026/03/106722RecruitingNot Applicable

Comparision of Pupil size in Pediatric Migraine patients with photophobia versus healthy controls and its correlation to the severity of headache

Ruby Moharana2 sites in 1 country120 target enrollmentStarted: March 31, 2026Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
120
Locations
2

Study Overview

Brief Summary

Migraine is one of the oldest reported diseases and the second most disabling disease worldwide. It affects almost 1.1 billion people worldwide and is a major cause of morbidity and disability specially in the young population. The ICHD-3 defines migraine as a primary headache disorder with attacks lasting 4-72 hours, typically unilateral, pulsating, moderate-to-severe, worsened by activity, and associated with nausea/vomiting and/or light/sound sensitivity (photophobia/phonophobia). Pediatric migraine is the most severe primary headache in children leading to decreased quality of life. The new ICHD-3 has increased the time window of childhood headaches for a diagnosis of primary migraine to 2–72 hours. ICHD-3 also takes cognizance of some factors unique to this condition, such as shorter pain durations and unilateral as well as bilateral pain locations. In 80 % of migraine attacks, photophobia or light sensitivity is a core component.  The exact cause of photophobia in migraine is not yet known and a number of causes have been postulated like cortical hypersensitivity to light, altered ocular parasympathetic outflow, and intrinsically photosensitive retinal ganglion cell pathways acting on dura-sensitive thalamocortical neurons which in turn can influence pupillary light reflexes. In a recent study we reported that the patients of migraine with photophobia have a larger pupil size as compared to patients with no history of migraine and that the severity of headache correlates with a larger pupil size. In this study we want to check the pupil sizes in patients of pediatric migraine with photophobia and whether it has any influence on the Migraine Disability Assessment (MIDAS) scores.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
8.00 Year(s) to 18.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Participants meeting ICHD 3 criteria for pediatric migraine Participants 8 to 18 years old with migraine and photophobia Participants having light as a trigger factor for the migraine attack Participants with best corrected visual acuity 6/6 for distance and N6 for near Participants with normal anterior and posterior segments with normal IOP Participants with normal neurological assessment and normal MRI brain Participants voluntarily giving informed assent and agreed to answer the pedMIDAS Questionnaire.

Exclusion Criteria

  • Participants with associated neurological disorder Participants with preexisting ocular conditions affecting pupil size Participants with recent eye surgeries Participants on any medications which can affect pupil size.

Investigators

Sponsor
Ruby Moharana
Sponsor Class
Other [Self funded]
Responsible Party
Principal Investigator
Principal Investigator

Ruby Moharana

Apex Eye Care

Study Sites (2)

Loading locations...

Similar Trials